These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 29220580)

  • 1. The influence of adiposity and acute exercise on circulating hepatokines in normal-weight and overweight/obese men.
    Sargeant JA; Aithal GP; Takamura T; Misu H; Takayama H; Douglas JA; Turner MC; Stensel DJ; Nimmo MA; Webb DR; Yates T; King JA
    Appl Physiol Nutr Metab; 2018 May; 43(5):482-490. PubMed ID: 29220580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of exercise intensity on circulating hepatokine concentrations in healthy men.
    Willis SA; Sargeant JA; Thackray AE; Yates T; Stensel DJ; Aithal GP; King JA
    Appl Physiol Nutr Metab; 2019 Oct; 44(10):1065-1072. PubMed ID: 31453723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute Hyperenergetic, High-Fat Feeding Increases Circulating FGF21, LECT2, and Fetuin-A in Healthy Men.
    Willis SA; Sargeant JA; Yates T; Takamura T; Takayama H; Gupta V; Brittain E; Crawford J; Parry SA; Thackray AE; Varela-Mato V; Stensel DJ; Woods RM; Hulston CJ; Aithal GP; King JA
    J Nutr; 2020 May; 150(5):1076-1085. PubMed ID: 31919514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating Concentrations of Insulin Resistance-Associated Hepatokines, Selenoprotein P and Leukocyte Cell-Derived Chemotaxin 2, during an Oral Glucose Tolerance Test in Humans.
    Mohri K; Misu H; Takayama H; Ishii KA; Kikuchi A; Lan F; Enyama Y; Takeshita Y; Saito Y; Kaneko S; Takamura T
    Biol Pharm Bull; 2019 Mar; 42(3):373-378. PubMed ID: 30606895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating growth arrest-specific 6 protein is associated with adiposity, systemic inflammation, and insulin resistance among overweight and obese adolescents.
    Hsiao FC; Lin YF; Hsieh PS; Chu NF; Shieh YS; Hsieh CH; Lee CH; Hung YJ
    J Clin Endocrinol Metab; 2013 Feb; 98(2):E267-74. PubMed ID: 23341490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Exercise Training and Weight Loss on Plasma Fetuin-A Levels and Insulin Sensitivity in Overweight Older Men.
    Blumenthal JB; Gitterman A; Ryan AS; Prior SJ
    J Diabetes Res; 2017; 2017():1492581. PubMed ID: 28770230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exercise-Induced Secretion of FGF21 and Follistatin Are Blocked by Pancreatic Clamp and Impaired in Type 2 Diabetes.
    Hansen JS; Pedersen BK; Xu G; Lehmann R; Weigert C; Plomgaard P
    J Clin Endocrinol Metab; 2016 Jul; 101(7):2816-25. PubMed ID: 27163358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attenuated fibroblast growth factor 21 response to acute aerobic exercise in obese individuals.
    Slusher AL; Whitehurst M; Zoeller RF; Mock JT; Maharaj M; Huang CJ
    Nutr Metab Cardiovasc Dis; 2015 Sep; 25(9):839-845. PubMed ID: 26141939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of a three-month combined exercise programme on fibroblast growth factor 21 and fetuin-A levels and arterial stiffness in obese women.
    Yang SJ; Hong HC; Choi HY; Yoo HJ; Cho GJ; Hwang TG; Baik SH; Choi DS; Kim SM; Choi KM
    Clin Endocrinol (Oxf); 2011 Oct; 75(4):464-9. PubMed ID: 21521346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibroblast growth factor 21 (FGF21) in human cerebrospinal fluid: relationship with plasma FGF21 and body adiposity.
    Tan BK; Hallschmid M; Adya R; Kern W; Lehnert H; Randeva HS
    Diabetes; 2011 Nov; 60(11):2758-62. PubMed ID: 21926274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FGF19 and FGF21 serum concentrations in human obesity and type 2 diabetes behave differently after diet- or surgically-induced weight loss.
    Gómez-Ambrosi J; Gallego-Escuredo JM; Catalán V; Rodríguez A; Domingo P; Moncada R; Valentí V; Salvador J; Giralt M; Villarroya F; Frühbeck G
    Clin Nutr; 2017 Jun; 36(3):861-868. PubMed ID: 27188262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FGF21 serum levels are related to insulin resistance, metabolic changes and obesity in Mexican people living with HIV (PLWH).
    Urraza-Robledo AI; Giralt M; González-Galarza FF; Villarroya F; Miranda Pérez AA; Ruiz Flores P; Gutiérrez Pérez ME; Domingo P; López-Márquez FC
    PLoS One; 2021; 16(5):e0252144. PubMed ID: 34019585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamic Changes in Circulating Endocrine FGF19 Subfamily and Fetuin-A in Response to Intralipid and Insulin Infusions in Healthy and PCOS Women.
    Ramanjaneya M; Bensila M; Bettahi I; Jerobin J; Samra TA; Aye MM; Alkasem M; Siveen KS; Sathyapalan T; Skarulis M; Atkin SL; Abou-Samra AB
    Front Endocrinol (Lausanne); 2020; 11():568500. PubMed ID: 33101202
    [No Abstract]   [Full Text] [Related]  

  • 14. Postprandial changes in glucose oxidation and insulin sensitivity in metabolic syndrome: Influence of fibroblast growth factor 21 and vitamin D status.
    Pathak K; Soares MJ; Zhao Y; James AP; Sherriff JL; Newsholme P
    Nutrition; 2017 May; 37():37-42. PubMed ID: 28359360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating leukocyte cell-derived chemotaxin 2 and fibroblast growth factor 21 are negatively associated with cardiorespiratory fitness in healthy volunteers.
    Malaikah S; Willis SA; Henson J; Sargeant JA; Yates T; Thackray AE; Goltz FR; Roberts MJ; Bernard-Deshong D; Aithal GP; Stensel DJ; King JA
    Appl Physiol Nutr Metab; 2023 Jun; 48(6):436-444. PubMed ID: 36867855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selenoprotein P is elevated in individuals with obesity, but is not independently associated with insulin resistance.
    Chen M; Liu B; Wilkinson D; Hutchison AT; Thompson CH; Wittert GA; Heilbronn LK
    Obes Res Clin Pract; 2017; 11(2):227-232. PubMed ID: 27524654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibroblast Growth Factor 21 and Fetuin-A in Obese Adolescents With and Without Type 2 Diabetes.
    Reinehr T; Karges B; Meissner T; Wiegand S; Fritsch M; Holl RW; Woelfle J
    J Clin Endocrinol Metab; 2015 Aug; 100(8):3004-10. PubMed ID: 26052728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protectin DX ameliorates palmitate-induced hepatic insulin resistance through AMPK/SIRT1-mediated modulation of fetuin-A and SeP expression.
    Jung TW; Ahn SH; Shin JW; Kim HC; Park ES; Abd El-Aty AM; Hacımüftüoğlu A; Song KH; Jeong JH
    Clin Exp Pharmacol Physiol; 2019 Oct; 46(10):898-909. PubMed ID: 31246318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibroblast growth factor 21, adiposity, and macronutrient balance in a healthy, pregnant population with overweight and obesity.
    Sutton EF; Morrison CD; Stephens JM; Redman LM
    Endocr Res; 2018 Nov; 43(4):275-283. PubMed ID: 29768065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Visceral fat area is a strong predictor of leukocyte cell-derived chemotaxin 2, a potential biomarker of dyslipidemia.
    Tanisawa K; Taniguchi H; Sun X; Ito T; Kawakami R; Sakamoto S; Higuchi M
    PLoS One; 2017; 12(3):e0173310. PubMed ID: 28278265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.